No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions (Q40897652)

24 September 2017

title

No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions (English)

1 reference

24 September 2017

1 reference

5

J Palmblad

1 reference

24 September 2017

S Asbrink

1

1 reference

24 September 2017

A Zickert

series ordinal

2

1 reference

24 September 2017

J Bratt

series ordinal

3

1 reference

24 September 2017

H Gyllenhammar

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

24 September 2017

published in

Biochemical Pharmacology

1 reference

24 September 2017

volume

59

1 reference

24 September 2017

issue

8

1 reference

24 September 2017

page(s)

1007-1013

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

24 September 2017

1 reference

Protective effects of carvedilol in the myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol, a new antihypertensive, prevents oxidation of human low density lipoprotein by macrophages and copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Stimulus-dependent transduction mechanisms for nitric oxide release in human polymorphonuclear neutrophil leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

The role of nitric oxide in lipoxin A4-induced polymorphonuclear neutrophil-dependent cytotoxicity to human vascular endothelium in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Lipoxin A4 induces neutrophil-dependent cytotoxicity for human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Inhibition of neutrophil-dependent cytotoxicity for human endothelial cells by antirheumatic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Effects of nitric oxide on chemotaxis and endotoxin-induced interleukin-8 production in human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Modulation of neutrophil migration by exogenous gaseous nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Development and characterization of essential fatty acid deficiency in human endothelial cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Mechanisms for luminol-augmented chemiluminescence from neutrophils induced by leukotriene B4 and N-formyl-methionyl-leucyl-phenylalanine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Measurement of methemoglobin formation from oxyhemoglobin. A real-time, continuous assay of nitric oxide release by human polymorphonuclear leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2899%2900393-7

10.1016/S0006-2952(99)00393-7

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference